EVANSTON, Ill.--(BUSINESS WIRE)--Northfield Laboratories Inc. (Nasdaq: NFLD) today reported its Chairman and CEO, Steven A. Gould, M.D., made a presentation to investors this morning at the Cowen & Company Global Health Care Conference in London. He provided an update on the Company’s progress in developing its human hemoglobin-based oxygen-carrying red cell substitute, PolyHeme®, for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available.
